Paydirt
MH
Insider

Mark W Hahn

Chief Financial Officer

Mark W Hahn (Chief Financial Officer) filed 7 Form 4 reports in the past 24 months (0 purchases, 7 sales), most often in VRNA. The largest single filing was $5.3M of VRNA (587,008 sh across 3 lots, as filed), executed May 1 2025. Data as of Nov 7 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$22.1M
shares × price, as filed
Last traded
Aug 1 2025
Filed Aug 5 2025
Open performance→
Volume by month
$9.9M$4.9M$0Dec 2024Jun 2025Dec 2025Jun 2026Dec 2024 · sells $4.9MMay 2025 · sells $9.9MJun 2025 · sells $4.6MAug 2025 · sells $2.7M
Buys $0 Sells $22.1M

Shares × price, as filed · by filing month · past 24 months

Most traded names
VRNA VRNA 0 buys · 7 sells 7 filings
Recent filings
VRNASALE Verona Pharma plc View filing → $2.7M
208,912 sh × $13.14
Exec Aug 1 2025
Filed Aug 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $4.6M
400,000 sh × $11.40
Exec Jun 11 2025
Filed Jun 13 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $3.7M
400,000 sh across 3 lots
Exec May 27 2025
Filed May 29 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $5.3M
587,008 sh across 3 lots
Exec May 1 2025
Filed May 5 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $811K
90,360 sh × $8.98
Exec Apr 29 2025
Filed May 1 2025 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $4.4M
881,960 sh across 3 lots
Exec Dec 4 2024
Filed Dec 6 2024 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $495K
98,704 sh × $5.01
Exec Nov 29 2024
Filed Dec 2 2024 · 5:30 PM ET VRNASALE Verona Pharma plc View filing → $569K
129,672 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET More filings →